Drug Information

Drug General Information
Drug ID
D03JFC
Former ID
DNC014111
Drug Name
3-(benzo[d]oxazol-2-yl)phenyl propylcarbamate
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530218]
Formula
C17H16N2O3
Canonical SMILES
CCCNC(=O)OC1=CC=CC(=C1)C2=NC3=CC=CC=C3O2
InChI
1S/C17H16N2O3/c1-2-10-18-17(20)21-13-7-5-6-12(11-13)16-19-14-8-3-4-9-15(14)22-16/h3-9,11H,2,10H2,1H3,(H,18,20)
InChIKey
VWTFAQPOTOAJGW-UHFFFAOYSA-N
PubChem Compound ID
44244229
Target and Pathway
Target(s) Fatty-acid amide hydrolase Target Info Inhibitor [530218]
BioCyc Pathway Anandamide degradation
KEGG Pathway Retrograde endocannabinoid signaling
PANTHER Pathway Anandamide degradation
References
Ref 530218Eur J Med Chem. 2009 Oct;44(10):4179-91. Epub 2009 May 22.Chiral 3-(4,5-dihydrooxazol-2-yl)phenyl alkylcarbamates as novel FAAH inhibitors: Insight into FAAH enantioselectivity by molecular docking and interaction fields.
Ref 530218Eur J Med Chem. 2009 Oct;44(10):4179-91. Epub 2009 May 22.Chiral 3-(4,5-dihydrooxazol-2-yl)phenyl alkylcarbamates as novel FAAH inhibitors: Insight into FAAH enantioselectivity by molecular docking and interaction fields.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.